C-TAP and Medicines Patent Pool Announce Global License for Spanish COVID-19 Test 23/11/2021 Raisa Santos The first non-exclusive license for a COVID-19 health tool – a serological antibody test that checks for the presence of anti-SARS-CoV-2 antibodies – has been finalised by the World Health Organization’s (WHO) COVID-19 Technology Access Pool (C-TAP) and the Medicines Patent Pool (MPP). The license, announced on Tuesday in partnership with the Spanish National Research […] Continue reading -> United States FDA Clears COVID Vaccine Boosters for All Adults Over 18 – Pfizer & Moderna 6 Months After Second Jab 19/11/2021 Elaine Ruth Fletcher The United States Food and Drug Administration (US FDA) on Friday gave its greenlight to the mass rollout of both Pfizer and Moderna COVID booster shots to all adults over the age of 18, from six months after a person’s second vaccine dose. J&J vaccine boosters would be authorized after just two months of the […] Continue reading -> Reflections on the ‘Other COP’ – Progress on Tobacco Control Despite COVID and Industry Attacks 19/11/2021 Gan Quan While the world was focused last week on the Glasgow Climate Conference (COP26), officials from 160 countries and the European Union gathered virtually to address another urgent global crisis – the crisis in tobacco consumption that is one of the largest causes of death worldwide, year after year. Otherwise known as COP9, the ninth Conference […] Continue reading -> Pfizer and Medicines Patent Pool Reach ‘Ground-breaking’ Voluntary Licensing Deal for New COVID-19 Treatment Pill 16/11/2021 Kerry Cullinan Pfizer has signed a voluntary license with the Medicines Patent Pool (MPP) to share the patents and knowledge to manufacture its new COVID-19 treatment drug, Paxlovid. According to the agreement, the MPP will be able to granting sub-licenses to qualified generic medicine manufacturers to supply the medicine in 95 countries, once regulatory authorization or approval […] Continue reading -> As COVID-19 Surges, Europe May Have to Introduce Harsh Measures, says WHO 12/11/2021 Kerry Cullinan It may be too late for many European countries to avoid harsh measures to try to curb the intense transmission of COVID-19, according to World Health Organization (WHO) officials on Friday. “Almost two million cases of COVID-19 were reported in Europe last week, the most in a single week in that region since the pandemic […] Continue reading -> Moderna Disputes That US Government Scientists Co-invented COVID mRNA Vaccine 12/11/2021 Raisa Santos Moderna has fired back against claims made by US National Institutes of Health (NIH) that its scientists at the National Institute of Allergy and Infectious Diseases (NIAD) helped to invent the crucial component of the pharma company’s COVID-19 vaccine, stating that the mRNA sequence was “selected exclusively” by Moderna scientists. “We do not agree that […] Continue reading -> Pandemic Treaty Offers Opportunity to Repair Fault Lines in COVID-19 Response – and Address Equity 09/11/2021 Kerry Cullinan An international pandemic treaty based on equity could be the antidote to current weaknesses and imbalances in the global response to COVID-19, according to a group of influential authors in a Lancet paper published on Tuesday. A number of the authors are associated with The Independent Panel for Pandemic Preparedness and Response chaired by Helen […] Continue reading -> Pfizer Says New Anti-Viral Drug Combination Cuts Risks Of Serious COVID-19 By 89% 05/11/2021 Aishwarya Tendolkar Pfizer Friday announced that its experimental COVID-19 oral antiviral drug PAXLOVID™ reduced risks of hospitalization and death by 89% among patients who received the drug within the first three days of their illness. The company said it had stopped its Phase 2/3 trial on the drug owing to the success rate seen in an interim […] Continue reading -> Europe’s Surging COVID-19 Cases Provide Lessons for Rest of World 04/11/2021 Kerry Cullinan Europe is now the epicentre of the COVID-19 pandemic and what it is experiencing now provides lessons for the rest of the world, according to World Health Organization (WHO) officials addressing a media briefing on Thursday. In addition, the lack of a systematic, multilateral approach to address this pandemic has only underscored the need for […] Continue reading -> As Indonesia greenlights Novavax COVID-19 Vaccine, Company Expects More Countries to Follow 02/11/2021 Kerry Cullinan Indonesia has granted emergency use authorization (EUA) for the COVID-19 vaccine developed by Novavax, which will be made by the Serum Institute of India (SII) and sold under the brand name Covovax. “This marks the first regulatory authorization worldwide of a protein-based COVID-19 vaccine based on Phase 3 clinical data demonstrating efficacy and a favourable […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
United States FDA Clears COVID Vaccine Boosters for All Adults Over 18 – Pfizer & Moderna 6 Months After Second Jab 19/11/2021 Elaine Ruth Fletcher The United States Food and Drug Administration (US FDA) on Friday gave its greenlight to the mass rollout of both Pfizer and Moderna COVID booster shots to all adults over the age of 18, from six months after a person’s second vaccine dose. J&J vaccine boosters would be authorized after just two months of the […] Continue reading -> Reflections on the ‘Other COP’ – Progress on Tobacco Control Despite COVID and Industry Attacks 19/11/2021 Gan Quan While the world was focused last week on the Glasgow Climate Conference (COP26), officials from 160 countries and the European Union gathered virtually to address another urgent global crisis – the crisis in tobacco consumption that is one of the largest causes of death worldwide, year after year. Otherwise known as COP9, the ninth Conference […] Continue reading -> Pfizer and Medicines Patent Pool Reach ‘Ground-breaking’ Voluntary Licensing Deal for New COVID-19 Treatment Pill 16/11/2021 Kerry Cullinan Pfizer has signed a voluntary license with the Medicines Patent Pool (MPP) to share the patents and knowledge to manufacture its new COVID-19 treatment drug, Paxlovid. According to the agreement, the MPP will be able to granting sub-licenses to qualified generic medicine manufacturers to supply the medicine in 95 countries, once regulatory authorization or approval […] Continue reading -> As COVID-19 Surges, Europe May Have to Introduce Harsh Measures, says WHO 12/11/2021 Kerry Cullinan It may be too late for many European countries to avoid harsh measures to try to curb the intense transmission of COVID-19, according to World Health Organization (WHO) officials on Friday. “Almost two million cases of COVID-19 were reported in Europe last week, the most in a single week in that region since the pandemic […] Continue reading -> Moderna Disputes That US Government Scientists Co-invented COVID mRNA Vaccine 12/11/2021 Raisa Santos Moderna has fired back against claims made by US National Institutes of Health (NIH) that its scientists at the National Institute of Allergy and Infectious Diseases (NIAD) helped to invent the crucial component of the pharma company’s COVID-19 vaccine, stating that the mRNA sequence was “selected exclusively” by Moderna scientists. “We do not agree that […] Continue reading -> Pandemic Treaty Offers Opportunity to Repair Fault Lines in COVID-19 Response – and Address Equity 09/11/2021 Kerry Cullinan An international pandemic treaty based on equity could be the antidote to current weaknesses and imbalances in the global response to COVID-19, according to a group of influential authors in a Lancet paper published on Tuesday. A number of the authors are associated with The Independent Panel for Pandemic Preparedness and Response chaired by Helen […] Continue reading -> Pfizer Says New Anti-Viral Drug Combination Cuts Risks Of Serious COVID-19 By 89% 05/11/2021 Aishwarya Tendolkar Pfizer Friday announced that its experimental COVID-19 oral antiviral drug PAXLOVID™ reduced risks of hospitalization and death by 89% among patients who received the drug within the first three days of their illness. The company said it had stopped its Phase 2/3 trial on the drug owing to the success rate seen in an interim […] Continue reading -> Europe’s Surging COVID-19 Cases Provide Lessons for Rest of World 04/11/2021 Kerry Cullinan Europe is now the epicentre of the COVID-19 pandemic and what it is experiencing now provides lessons for the rest of the world, according to World Health Organization (WHO) officials addressing a media briefing on Thursday. In addition, the lack of a systematic, multilateral approach to address this pandemic has only underscored the need for […] Continue reading -> As Indonesia greenlights Novavax COVID-19 Vaccine, Company Expects More Countries to Follow 02/11/2021 Kerry Cullinan Indonesia has granted emergency use authorization (EUA) for the COVID-19 vaccine developed by Novavax, which will be made by the Serum Institute of India (SII) and sold under the brand name Covovax. “This marks the first regulatory authorization worldwide of a protein-based COVID-19 vaccine based on Phase 3 clinical data demonstrating efficacy and a favourable […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Reflections on the ‘Other COP’ – Progress on Tobacco Control Despite COVID and Industry Attacks 19/11/2021 Gan Quan While the world was focused last week on the Glasgow Climate Conference (COP26), officials from 160 countries and the European Union gathered virtually to address another urgent global crisis – the crisis in tobacco consumption that is one of the largest causes of death worldwide, year after year. Otherwise known as COP9, the ninth Conference […] Continue reading -> Pfizer and Medicines Patent Pool Reach ‘Ground-breaking’ Voluntary Licensing Deal for New COVID-19 Treatment Pill 16/11/2021 Kerry Cullinan Pfizer has signed a voluntary license with the Medicines Patent Pool (MPP) to share the patents and knowledge to manufacture its new COVID-19 treatment drug, Paxlovid. According to the agreement, the MPP will be able to granting sub-licenses to qualified generic medicine manufacturers to supply the medicine in 95 countries, once regulatory authorization or approval […] Continue reading -> As COVID-19 Surges, Europe May Have to Introduce Harsh Measures, says WHO 12/11/2021 Kerry Cullinan It may be too late for many European countries to avoid harsh measures to try to curb the intense transmission of COVID-19, according to World Health Organization (WHO) officials on Friday. “Almost two million cases of COVID-19 were reported in Europe last week, the most in a single week in that region since the pandemic […] Continue reading -> Moderna Disputes That US Government Scientists Co-invented COVID mRNA Vaccine 12/11/2021 Raisa Santos Moderna has fired back against claims made by US National Institutes of Health (NIH) that its scientists at the National Institute of Allergy and Infectious Diseases (NIAD) helped to invent the crucial component of the pharma company’s COVID-19 vaccine, stating that the mRNA sequence was “selected exclusively” by Moderna scientists. “We do not agree that […] Continue reading -> Pandemic Treaty Offers Opportunity to Repair Fault Lines in COVID-19 Response – and Address Equity 09/11/2021 Kerry Cullinan An international pandemic treaty based on equity could be the antidote to current weaknesses and imbalances in the global response to COVID-19, according to a group of influential authors in a Lancet paper published on Tuesday. A number of the authors are associated with The Independent Panel for Pandemic Preparedness and Response chaired by Helen […] Continue reading -> Pfizer Says New Anti-Viral Drug Combination Cuts Risks Of Serious COVID-19 By 89% 05/11/2021 Aishwarya Tendolkar Pfizer Friday announced that its experimental COVID-19 oral antiviral drug PAXLOVID™ reduced risks of hospitalization and death by 89% among patients who received the drug within the first three days of their illness. The company said it had stopped its Phase 2/3 trial on the drug owing to the success rate seen in an interim […] Continue reading -> Europe’s Surging COVID-19 Cases Provide Lessons for Rest of World 04/11/2021 Kerry Cullinan Europe is now the epicentre of the COVID-19 pandemic and what it is experiencing now provides lessons for the rest of the world, according to World Health Organization (WHO) officials addressing a media briefing on Thursday. In addition, the lack of a systematic, multilateral approach to address this pandemic has only underscored the need for […] Continue reading -> As Indonesia greenlights Novavax COVID-19 Vaccine, Company Expects More Countries to Follow 02/11/2021 Kerry Cullinan Indonesia has granted emergency use authorization (EUA) for the COVID-19 vaccine developed by Novavax, which will be made by the Serum Institute of India (SII) and sold under the brand name Covovax. “This marks the first regulatory authorization worldwide of a protein-based COVID-19 vaccine based on Phase 3 clinical data demonstrating efficacy and a favourable […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Pfizer and Medicines Patent Pool Reach ‘Ground-breaking’ Voluntary Licensing Deal for New COVID-19 Treatment Pill 16/11/2021 Kerry Cullinan Pfizer has signed a voluntary license with the Medicines Patent Pool (MPP) to share the patents and knowledge to manufacture its new COVID-19 treatment drug, Paxlovid. According to the agreement, the MPP will be able to granting sub-licenses to qualified generic medicine manufacturers to supply the medicine in 95 countries, once regulatory authorization or approval […] Continue reading -> As COVID-19 Surges, Europe May Have to Introduce Harsh Measures, says WHO 12/11/2021 Kerry Cullinan It may be too late for many European countries to avoid harsh measures to try to curb the intense transmission of COVID-19, according to World Health Organization (WHO) officials on Friday. “Almost two million cases of COVID-19 were reported in Europe last week, the most in a single week in that region since the pandemic […] Continue reading -> Moderna Disputes That US Government Scientists Co-invented COVID mRNA Vaccine 12/11/2021 Raisa Santos Moderna has fired back against claims made by US National Institutes of Health (NIH) that its scientists at the National Institute of Allergy and Infectious Diseases (NIAD) helped to invent the crucial component of the pharma company’s COVID-19 vaccine, stating that the mRNA sequence was “selected exclusively” by Moderna scientists. “We do not agree that […] Continue reading -> Pandemic Treaty Offers Opportunity to Repair Fault Lines in COVID-19 Response – and Address Equity 09/11/2021 Kerry Cullinan An international pandemic treaty based on equity could be the antidote to current weaknesses and imbalances in the global response to COVID-19, according to a group of influential authors in a Lancet paper published on Tuesday. A number of the authors are associated with The Independent Panel for Pandemic Preparedness and Response chaired by Helen […] Continue reading -> Pfizer Says New Anti-Viral Drug Combination Cuts Risks Of Serious COVID-19 By 89% 05/11/2021 Aishwarya Tendolkar Pfizer Friday announced that its experimental COVID-19 oral antiviral drug PAXLOVID™ reduced risks of hospitalization and death by 89% among patients who received the drug within the first three days of their illness. The company said it had stopped its Phase 2/3 trial on the drug owing to the success rate seen in an interim […] Continue reading -> Europe’s Surging COVID-19 Cases Provide Lessons for Rest of World 04/11/2021 Kerry Cullinan Europe is now the epicentre of the COVID-19 pandemic and what it is experiencing now provides lessons for the rest of the world, according to World Health Organization (WHO) officials addressing a media briefing on Thursday. In addition, the lack of a systematic, multilateral approach to address this pandemic has only underscored the need for […] Continue reading -> As Indonesia greenlights Novavax COVID-19 Vaccine, Company Expects More Countries to Follow 02/11/2021 Kerry Cullinan Indonesia has granted emergency use authorization (EUA) for the COVID-19 vaccine developed by Novavax, which will be made by the Serum Institute of India (SII) and sold under the brand name Covovax. “This marks the first regulatory authorization worldwide of a protein-based COVID-19 vaccine based on Phase 3 clinical data demonstrating efficacy and a favourable […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
As COVID-19 Surges, Europe May Have to Introduce Harsh Measures, says WHO 12/11/2021 Kerry Cullinan It may be too late for many European countries to avoid harsh measures to try to curb the intense transmission of COVID-19, according to World Health Organization (WHO) officials on Friday. “Almost two million cases of COVID-19 were reported in Europe last week, the most in a single week in that region since the pandemic […] Continue reading -> Moderna Disputes That US Government Scientists Co-invented COVID mRNA Vaccine 12/11/2021 Raisa Santos Moderna has fired back against claims made by US National Institutes of Health (NIH) that its scientists at the National Institute of Allergy and Infectious Diseases (NIAD) helped to invent the crucial component of the pharma company’s COVID-19 vaccine, stating that the mRNA sequence was “selected exclusively” by Moderna scientists. “We do not agree that […] Continue reading -> Pandemic Treaty Offers Opportunity to Repair Fault Lines in COVID-19 Response – and Address Equity 09/11/2021 Kerry Cullinan An international pandemic treaty based on equity could be the antidote to current weaknesses and imbalances in the global response to COVID-19, according to a group of influential authors in a Lancet paper published on Tuesday. A number of the authors are associated with The Independent Panel for Pandemic Preparedness and Response chaired by Helen […] Continue reading -> Pfizer Says New Anti-Viral Drug Combination Cuts Risks Of Serious COVID-19 By 89% 05/11/2021 Aishwarya Tendolkar Pfizer Friday announced that its experimental COVID-19 oral antiviral drug PAXLOVID™ reduced risks of hospitalization and death by 89% among patients who received the drug within the first three days of their illness. The company said it had stopped its Phase 2/3 trial on the drug owing to the success rate seen in an interim […] Continue reading -> Europe’s Surging COVID-19 Cases Provide Lessons for Rest of World 04/11/2021 Kerry Cullinan Europe is now the epicentre of the COVID-19 pandemic and what it is experiencing now provides lessons for the rest of the world, according to World Health Organization (WHO) officials addressing a media briefing on Thursday. In addition, the lack of a systematic, multilateral approach to address this pandemic has only underscored the need for […] Continue reading -> As Indonesia greenlights Novavax COVID-19 Vaccine, Company Expects More Countries to Follow 02/11/2021 Kerry Cullinan Indonesia has granted emergency use authorization (EUA) for the COVID-19 vaccine developed by Novavax, which will be made by the Serum Institute of India (SII) and sold under the brand name Covovax. “This marks the first regulatory authorization worldwide of a protein-based COVID-19 vaccine based on Phase 3 clinical data demonstrating efficacy and a favourable […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Moderna Disputes That US Government Scientists Co-invented COVID mRNA Vaccine 12/11/2021 Raisa Santos Moderna has fired back against claims made by US National Institutes of Health (NIH) that its scientists at the National Institute of Allergy and Infectious Diseases (NIAD) helped to invent the crucial component of the pharma company’s COVID-19 vaccine, stating that the mRNA sequence was “selected exclusively” by Moderna scientists. “We do not agree that […] Continue reading -> Pandemic Treaty Offers Opportunity to Repair Fault Lines in COVID-19 Response – and Address Equity 09/11/2021 Kerry Cullinan An international pandemic treaty based on equity could be the antidote to current weaknesses and imbalances in the global response to COVID-19, according to a group of influential authors in a Lancet paper published on Tuesday. A number of the authors are associated with The Independent Panel for Pandemic Preparedness and Response chaired by Helen […] Continue reading -> Pfizer Says New Anti-Viral Drug Combination Cuts Risks Of Serious COVID-19 By 89% 05/11/2021 Aishwarya Tendolkar Pfizer Friday announced that its experimental COVID-19 oral antiviral drug PAXLOVID™ reduced risks of hospitalization and death by 89% among patients who received the drug within the first three days of their illness. The company said it had stopped its Phase 2/3 trial on the drug owing to the success rate seen in an interim […] Continue reading -> Europe’s Surging COVID-19 Cases Provide Lessons for Rest of World 04/11/2021 Kerry Cullinan Europe is now the epicentre of the COVID-19 pandemic and what it is experiencing now provides lessons for the rest of the world, according to World Health Organization (WHO) officials addressing a media briefing on Thursday. In addition, the lack of a systematic, multilateral approach to address this pandemic has only underscored the need for […] Continue reading -> As Indonesia greenlights Novavax COVID-19 Vaccine, Company Expects More Countries to Follow 02/11/2021 Kerry Cullinan Indonesia has granted emergency use authorization (EUA) for the COVID-19 vaccine developed by Novavax, which will be made by the Serum Institute of India (SII) and sold under the brand name Covovax. “This marks the first regulatory authorization worldwide of a protein-based COVID-19 vaccine based on Phase 3 clinical data demonstrating efficacy and a favourable […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Pandemic Treaty Offers Opportunity to Repair Fault Lines in COVID-19 Response – and Address Equity 09/11/2021 Kerry Cullinan An international pandemic treaty based on equity could be the antidote to current weaknesses and imbalances in the global response to COVID-19, according to a group of influential authors in a Lancet paper published on Tuesday. A number of the authors are associated with The Independent Panel for Pandemic Preparedness and Response chaired by Helen […] Continue reading -> Pfizer Says New Anti-Viral Drug Combination Cuts Risks Of Serious COVID-19 By 89% 05/11/2021 Aishwarya Tendolkar Pfizer Friday announced that its experimental COVID-19 oral antiviral drug PAXLOVID™ reduced risks of hospitalization and death by 89% among patients who received the drug within the first three days of their illness. The company said it had stopped its Phase 2/3 trial on the drug owing to the success rate seen in an interim […] Continue reading -> Europe’s Surging COVID-19 Cases Provide Lessons for Rest of World 04/11/2021 Kerry Cullinan Europe is now the epicentre of the COVID-19 pandemic and what it is experiencing now provides lessons for the rest of the world, according to World Health Organization (WHO) officials addressing a media briefing on Thursday. In addition, the lack of a systematic, multilateral approach to address this pandemic has only underscored the need for […] Continue reading -> As Indonesia greenlights Novavax COVID-19 Vaccine, Company Expects More Countries to Follow 02/11/2021 Kerry Cullinan Indonesia has granted emergency use authorization (EUA) for the COVID-19 vaccine developed by Novavax, which will be made by the Serum Institute of India (SII) and sold under the brand name Covovax. “This marks the first regulatory authorization worldwide of a protein-based COVID-19 vaccine based on Phase 3 clinical data demonstrating efficacy and a favourable […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Pfizer Says New Anti-Viral Drug Combination Cuts Risks Of Serious COVID-19 By 89% 05/11/2021 Aishwarya Tendolkar Pfizer Friday announced that its experimental COVID-19 oral antiviral drug PAXLOVID™ reduced risks of hospitalization and death by 89% among patients who received the drug within the first three days of their illness. The company said it had stopped its Phase 2/3 trial on the drug owing to the success rate seen in an interim […] Continue reading -> Europe’s Surging COVID-19 Cases Provide Lessons for Rest of World 04/11/2021 Kerry Cullinan Europe is now the epicentre of the COVID-19 pandemic and what it is experiencing now provides lessons for the rest of the world, according to World Health Organization (WHO) officials addressing a media briefing on Thursday. In addition, the lack of a systematic, multilateral approach to address this pandemic has only underscored the need for […] Continue reading -> As Indonesia greenlights Novavax COVID-19 Vaccine, Company Expects More Countries to Follow 02/11/2021 Kerry Cullinan Indonesia has granted emergency use authorization (EUA) for the COVID-19 vaccine developed by Novavax, which will be made by the Serum Institute of India (SII) and sold under the brand name Covovax. “This marks the first regulatory authorization worldwide of a protein-based COVID-19 vaccine based on Phase 3 clinical data demonstrating efficacy and a favourable […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Europe’s Surging COVID-19 Cases Provide Lessons for Rest of World 04/11/2021 Kerry Cullinan Europe is now the epicentre of the COVID-19 pandemic and what it is experiencing now provides lessons for the rest of the world, according to World Health Organization (WHO) officials addressing a media briefing on Thursday. In addition, the lack of a systematic, multilateral approach to address this pandemic has only underscored the need for […] Continue reading -> As Indonesia greenlights Novavax COVID-19 Vaccine, Company Expects More Countries to Follow 02/11/2021 Kerry Cullinan Indonesia has granted emergency use authorization (EUA) for the COVID-19 vaccine developed by Novavax, which will be made by the Serum Institute of India (SII) and sold under the brand name Covovax. “This marks the first regulatory authorization worldwide of a protein-based COVID-19 vaccine based on Phase 3 clinical data demonstrating efficacy and a favourable […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
As Indonesia greenlights Novavax COVID-19 Vaccine, Company Expects More Countries to Follow 02/11/2021 Kerry Cullinan Indonesia has granted emergency use authorization (EUA) for the COVID-19 vaccine developed by Novavax, which will be made by the Serum Institute of India (SII) and sold under the brand name Covovax. “This marks the first regulatory authorization worldwide of a protein-based COVID-19 vaccine based on Phase 3 clinical data demonstrating efficacy and a favourable […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy